Avalon Global Asset Management LLC Gilead Sciences, Inc. Transaction History

Avalon Global Asset Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $2.13 Million - $2.51 Million	-30,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.16 Million - $2.56 Million	30,000	30,000 $2.43 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Avalon Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avalon Global Asset Management LLC with notifications on news.